Results 111 to 120 of about 1,214 (169)

Non-Small-Cell Lung Cancers (NSCLCs) Harboring RET Gene Fusion, from Their Discovery to the Advent of New Selective Potent RET Inhibitors: "Shadows and Fogs". [PDF]

Cancers (Basel)
Spitaleri G, Trillo Aliaga P, Attili I, Del Signore E, Corvaja C, Pellizzari G, Katrini J, Passaro A, de Marinis F.   +8 more
europepmc   +1 more source

Molecular Characterisations and the Association with Clinical Factors in <i>RET</i> Fusion-Positive NSCLC: A Retrospective Study of the Single Center Cohort. [PDF]

Cancer Manag Res
Li X, Zhao P, Cui H, Zhang T, Sun W, Li H.   +5 more
europepmc   +1 more source

RET Inhibitors in RET Fusion-Positive Lung Cancers: Past, Present, and Future. [PDF]

Drugs
Chen MF, Repetto M, Wilhelm C, Drilon A.
europepmc   +1 more source

Clinical Activity of Selpercatinib in RET-mutant Pheochromocytoma.

J Clin Endocrinol Metab
Deschler-Baier B, Konda B, Massarelli E, Hu MI, Wirth LJ, Xu X, Wright J, Clifton-Bligh RJ.   +7 more
europepmc   +1 more source

Librettoスーパーブック

, 1996
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Libretto

2022
exaly   +3 more sources

The Libretto

2006
Allen Cohen, Steven L. Rosenhaus
exaly   +2 more sources

Libretto

2013
exaly   +2 more sources